Could Semaglutide Be the Next Big Anti-Inflammatory? New Research Uncovers Surprising Benefits Beyond Blood Sugar Control
Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is primarily prescribed for type 2 diabetes and obesity management. Emerging research indicates that semaglutide also possesses anti-inflammatory properties, which may contribute to its cardiovascular benefits and … Continue